Showing results (401-410 of 530) with videos related to
Sort By:
Pageof 53
Health and Quality of Life Outcomes|February 20, 2016
Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Antonia V Bennett, Amylou C Dueck, Sandra A Mitchell, et al.Clinical Trials (London, England)|May 27, 2017
Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAETito R Mendoza, Amylou C Dueck, Antonia V Bennett, et al.Journal of the National Cancer Institute|October 6, 2005
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatmentBrenda K Edwards, Martin L Brown, Phyllis A Wingo, et al.Lung Cancer (Amsterdam, Netherlands)|October 11, 2021
Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: A nested cohort within the PRO-TECT pragmatic trial (AFT-39)Gita N Mody, Angela M Stover, Mian Wang, et al.Cancer|May 4, 2011
Phase 1/2 study of everolimus in advanced hepatocellular carcinomaAndrew X Zhu, Thomas A Abrams, Rebecca Miksad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2023
Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39)Victoria S Blinder, Allison M Deal, Brenda Ginos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing PanelsZsofia K Stadler, Francesca Battaglin, Sumit Middha, et al.JAMA Oncology|March 23, 2018
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal CancerAndrea Cercek, Campbell S D Roxburgh, Paul Strombom, et al.Cancer|November 23, 2016
Clinical and genetic determinants of ovarian metastases from colorectal cancerKaruna Ganesh, Ronak H Shah, Efsevia Vakiani, et al.Clinical and Translational Medicine|May 29, 2025
Responsiveness of different MET tumour alterations to type I and type II MET inhibitorsYonina R Murciano-Goroff, Valentina Foglizzo, Jason Chang, et al.Pageof 53